Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin.
Passage of poliovirus (PV) or foot-and-mouth disease virus (FMDV) in the presence of ribavirin selected for viruses with decreased sensitivity to R, which included different mutations in their polymerase (3D): G64S located in the finger subdomain in the case of PV and M296I located within loop beta9-alpha11 at the active site in the case of FMDV. To investigate why disparate substitutions were selected in two closely related 3Ds, we constructed FMDVs with a 3D that included either G62S (the equivalent replacement in FMDV of PV G64S), M296I, or both substitutions. G62S, but not M296I, inflicts upon FMDV a strong selective disadvantage which is partially compensated for by the substitution M296I. The corresponding mutant polymerases, 3D(G62S), 3D(M296I), and 3D(G62S-M296I), were analyzed functionally and structurally. G62S in 3D impairs RNA-binding, polymerization, and R monophosphate incorporation activities. The X-ray structures of the 3D(G62S)-RNA, 3D(M296I)-RNA, and 3D(G62S-M296I)-RNA complexes show that although the two positions are separated by 13.1 A, the loops where the replacements reside are tightly connected through an extensive network of interactions that reach the polymerase active site. In particular, G62S seems to restrict the flexibility of loop beta9-alpha11 and, as a consequence, the flexibility of the active site and its ability to bind the RNA template. Thus, a localized change in the finger subdomain of 3D may affect the catalytic domain. The results provide a structural interpretation of why different amino acid substitutions were selected to confer R resistance in closely related viruses and reveal a complex network of intra-3D interactions that can affect the recognition of both the RNA template and incoming nucleotide.
Ferrer-Orta
Cristina
C
Institut de Biología Molecular de Barcelona (CSIC), Parc Cientific de Barcelona, Baldiri i Reixac 10, E-08028 Barcelona, Spain.
Sierra
Macarena
M
Agudo
Rubén
R
de la Higuera
Ignacio
I
Arias
Armando
A
Pérez-Luque
Rosa
R
Escarmís
Cristina
C
Domingo
Esteban
E
Verdaguer
Nuria
N
D000595:Amino Acid Sequence; D000818:Animals; D020134:Catalytic Domain; D002460:Cell Line; D006224:Cricetinae; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005536:Foot-and-Mouth Disease / Q000821:virology; D029544:Foot-and-Mouth Disease Virus / Q000737:chemistry / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009154:Mutation; D011485:Protein Binding; D012254:Ribavirin / Q000494:pharmacology*; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism
D004791:Enzyme Inhibitors; D014764:Viral Proteins; D012254:Ribavirin; D012321:DNA-Directed RNA Polymerases
Biochemistry. 2004 May 11;43(18):5149-58
15122880
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94
12754380
Nature. 2006 Jan 19;439(7074):344-8
16327776
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9463-8
17517631
Biochemistry. 2003 Sep 9;42(35):10462-71
12950173
Methods Enzymol. 1997;276:307-26
27754618
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10027-32
10468556
J Biol Chem. 2000 Feb 25;275(8):5329-36
10681506
J Virol. 2007 Feb;81(4):2012-24
17151116
Virology. 1983 Jul 30;128(2):310-8
6310859
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6895-900
11371613
PLoS Pathog. 2005 Oct;1(2):e11
16220146
PLoS One. 2009;4(5):e5554
19436746
Curr Top Microbiol Immunol. 2008;320:137-56
18268843
J Virol. 2000 Sep;74(18):8316-23
10954530
J Virol. 2004 Nov;78(21):11678-85
15479809
Virus Res. 2005 Feb;107(2):129-39
15649559
Virus Res. 2005 Feb;107(2):165-71
15649562
J Mol Biol. 1996 Nov 29;264(2):255-67
8951375
Virology. 2003 Jul 5;311(2):339-49
12842623
J Virol. 2007 Apr;81(7):3583-96
17251299
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
J Mol Biol. 2005 Nov 11;353(5):1021-32
16216271
Biochemistry. 2004 May 11;43(18):5126-37
15122878
Nat Med. 2000 Dec;6(12):1375-9
11100123
Gastroenterology. 2007 May;132(5):2050-2
17484896
J Biol Chem. 2004 Nov 5;279(45):47212-21
15294895
Rev Med Virol. 2006 Jan-Feb;16(1):37-48
16287208
J Virol. 2001 May;75(10):4771-9
11312349
EMBO J. 2004 Sep 1;23(17):3462-71
15306852
J Virol. 2008 Dec;82(24):12346-55
18829745